Showing results (601-610 of 712) with videos related to
Sort By:
Pageof 72
Bioorganic & Medicinal Chemistry|March 21, 2008
Modifying the N-terminus of polyamides: PyImPyIm has improved sequence specificity over f-ImPyImToni Brown, Hilary Mackay, Mark Turlington, et al.Science (New York, N.Y.)|July 17, 2012
Attenuated vaccines can recombine to form virulent field virusesSang-Won Lee, Philip F Markham, Mauricio J C Coppo, et al.Scientific Reports|January 22, 2020
Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradationSylwia Jones, Peter J King, Costin N Antonescu, et al.Plos One|December 7, 2018
Determination of the minimum protective dose of a glycoprotein-G-deficient infectious laryngotracheitis virus vaccine delivered via eye-drop to week-old chickensMesula G Korsa, Joanne M Devlin, Carol A Hartley, et al.Bioorganic & Medicinal Chemistry Letters|May 31, 2021
Effects of N-terminus modified Hx-amides on DNA binding affinity, sequence specificity, cellular uptake, and gene expressionKonstantinos Kiakos, Vijay Satam, Pravin C Patil, et al.Avian Diseases|April 25, 2014
Cross-protective immune responses between genotypically distinct lineages of infectious laryngotracheitis virusesSang-Won Lee, Philip F Markham, Mauricio J C Coppo, et al.Allergy|October 7, 2016
Myeloid-derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in chronic obstructive pulmonary diseaseA K A Wright, C Newby, R A Hartley, et al.Journal of Medicinal Chemistry|February 20, 2004
Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8' ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimersStephen J Gregson, Philip W Howard, Darren R Gullick, et al.Plos One|March 19, 2015
Growth kinetics and transmission potential of existing and emerging field strains of infectious laryngotracheitis virusSang-Won Lee, Carol A Hartley, Mauricio J C Coppo, et al.British Journal of Cancer|December 4, 2015
Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedinB Colmegna, S Uboldi, R Frapolli, et al.Pageof 72